L
Lucid Diagnostics Inc. (LUCD)
NCM – Real Time Price. Currency in USD
1.04
+0.02 (1.96%)
At close: May 12, 2026, 4:00 PM EDT
1.07
+0.03 (3.13%)
Pre-market: May 13, 2026, 4:00 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.04
+0.02 (1.96%)
At close: May 12, 2026, 4:00 PM EDT
1.07
+0.03 (3.13%)
Pre-market: May 13, 2026, 4:00 AM EDT
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company’s flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
| Name | Position |
|---|---|
| Dr. Amitabh Chak M.D. | Co-Founder & Strategic Advisor |
| Dr. Brian J. deGuzman M.D. | Chief Technology & Compliance Officer |
| Dr. Joseph Willis M.D. | Co-founder & Strategic Advisor |
| Dr. Lishan Aklog M.D. | Chairman & CEO |
| Dr. Sanford D. Markowitz M.D., Ph.D. | Co-Founder & Strategic Advisor |
| Dr. Suman M. Verma M.D., Ph.D. | Senior VP & Chief Scientific Officer |
| Helen Moinova Ph.D. | Co-Founder & Strategic Advisor |
| Mr. Matthew Riley | Director of Investor Relations |
| Mr. Michael Adam Gordon | General Counsel & Secretary |
| Mr. Shaun M. O'Neill M.B.A. | President & COO |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | DEF 14A | formdef14a.htm |
| 2026-04-24 | 8-K | form8-k.htm |
| 2026-04-23 | 8-K | form8-k.htm |
| 2026-04-20 | PRE 14A | formpre14a.htm |
| 2026-04-03 | S-8 | forms-8.htm |
| 2026-03-25 | 10-K | lucd20251231_10k.htm |
| 2025-12-05 | S-3 | forms3.htm |
| 2025-11-12 | 10-Q | form10-q.htm |
| 2025-09-25 | 8-K | form8-k.htm |
| 2025-09-11 | 8-K | form8-k.htm |